There are no issues with this company. They are working their way through approval from the TGA. Everything is on track. The sell off is driven by impatience and liquidity requirements. Plus one major fund sold off when the price fell. They had to under their investment mandate. They are nearly out but continue to sell on any sign off a price rise which drops the price again. In six months time this company will have an estimated $1b royalty arrangement with a global pharma company to distribute the first product. Other products will follow. You need to assess for yourself but now is a great time to drive price through demand. The demand charts have turned. My forecast is the price will increase or should increase to $1 by September when a pharma deal is close. Then it will march to $2 when the TGA gives conditional approval in November. I own a significant number of shares and understand the strategy being deployed by management.
This is not advice.
DYOR
LTP Price at posting:
34.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)